Table 1. Snapshot of Asia Pacific Pharmacogenomics Market, 2019-2030 18
Table 2. Web-based Resources of Pharmacogenomics 23
Table 3. Main Product Trends and Market Opportunities in Asia Pacific Pharmacogenomics Market 33
Table 4. Asia Pacific Pharmacogenomics Market by Service, 2019-2030, $ mn 41
Table 5. Medicine/Gene Matching in Pharmacogenetic Testing 46
Table 6. Asia Pacific Pharmacogenomics Market by Technology, 2019-2030, $ mn 48
Table 7. Asia Pacific Pharmacogenomics Market by Application, 2019-2030, $ mn 56
Table 8. Important Drug-Gene Pairs Relevant to Neurology and Psychiatry 61
Table 9. Asia Pacific Pharmacogenomics Market by End User, 2019-2030, $ mn 65
Table 10. APAC Pharmacogenomics Market by Country, 2019-2030, $ mn 71
Table 11. Japan Pharmacogenomics Market by Service, 2019-2030, $ mn 75
Table 12. Japan Pharmacogenomics Market by Technology, 2019-2030, $ mn 75
Table 13. Japan Pharmacogenomics Market by Application, 2019-2030, $ mn 75
Table 14. China Pharmacogenomics Market by Service, 2019-2030, $ mn 77
Table 15. China Pharmacogenomics Market by Technology, 2019-2030, $ mn 77
Table 16. China Pharmacogenomics Market by Application, 2019-2030, $ mn 77
Table 17. Australia Pharmacogenomics Market by Service, 2019-2030, $ mn 79
Table 18. Australia Pharmacogenomics Market by Technology, 2019-2030, $ mn 79
Table 19. Australia Pharmacogenomics Market by Application, 2019-2030, $ mn 79
Table 20. India Pharmacogenomics Market by Service, 2019-2030, $ mn 81
Table 21. India Pharmacogenomics Market by Technology, 2019-2030, $ mn 81
Table 22. India Pharmacogenomics Market by Application, 2019-2030, $ mn 81
Table 23. South Korea Pharmacogenomics Market by Service, 2019-2030, $ mn 83
Table 24. South Korea Pharmacogenomics Market by Technology, 2019-2030, $ mn 83
Table 25. South Korea Pharmacogenomics Market by Application, 2019-2030, $ mn 83
Table 26. Pharmacogenomics Market in Rest of APAC by Country, 2019-2030, $ mn 85
Table 27. Product Approvals by Company, January 2016 April 2019 88
Table 28. Breakdown of Asia Pacific Market by Key Vendor, 2019, % 88
Table 29. 23andMe, Inc.: Company Snapshot 91
Table 30. 23andMe, Inc.: Business Segmentation 91
Table 31. 23andMe, Inc.: Product Portfolio 92
Table 32. 23andMe, Inc.: Revenue, 2016-2018, $ mn 92
Table 33. 23andMe, Inc.: Recent Developments 92
Table 34. Risk Evaluation for Investing in Asia Pacific Market, 2019-2030 117
Table 35. Critical Success Factors and Key Takeaways 120

LIST OF FIGURE

Figure 1. Research Method Flow Chart 11
Figure 2. Breakdown of Primary Research 13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 17
Figure 5. Asia Pacific Pharmacogenomics Market, 2019-2030, $ mn 20
Figure 6. An Overall Process of How Pharmacogenomics Functions in a Clinical Practice 22
Figure 7. Impact of COVID-19 on Business 24
Figure 8. Primary Drivers and Impact Factors of Asia Pacific Pharmacogenomics Market 26
Figure 9. World Top 10 Causes of Deaths, 2016 29
Figure 10. Primary Restraints and Impact Factors of Asia Pacific Pharmacogenomics Market 30
Figure 11. Consecutive Phases and Associated Challenges in Pharmacogenomics 32
Figure 12. Investment Opportunity Analysis 34
Figure 13. Porters Fiver Forces Analysis of Asia Pacific Pharmacogenomics Market 37
Figure 14. Breakdown of Asia Pacific Pharmacogenomics Market by Service, 2019-2030, % of Revenue 41
Figure 15. Asia Pacific Addressable Market Cap in 2020-2030 by Service, Value ($ mn) and Share (%) 42
Figure 16. Asia Pacific Pharmacogenomics Market: Genotyping, 2019-2030, $ mn 43
Figure 17. Asia Pacific Pharmacogenomics Market: SNP Identification, 2019-2030, $ mn 44
Figure 18. Asia Pacific Pharmacogenomics Market: Diagnostics, 2019-2030, $ mn 45
Figure 19. Asia Pacific Pharmacogenomics Market: Other Services, 2019-2030, $ mn 47
Figure 20. Breakdown of Asia Pacific Pharmacogenomics Market by Technology, 2019-2030, % of Sales Revenue 48
Figure 21. Asia Pacific Addressable Market Cap in 2020-2030 by Technology, Value ($ mn) and Share (%) 49
Figure 22. Asia Pacific Pharmacogenomics Market: Polymerase Chain Reaction (PCR), 2019-2030, $ mn 50
Figure 23. Asia Pacific Pharmacogenomics Market: Microarray, 2019-2030, $ mn 51
Figure 24. Asia Pacific Pharmacogenomics Market: Sequencing, 2019-2030, $ mn 52
Figure 25. Asia Pacific Pharmacogenomics Market: Electrophoresis, 2019-2030, $ mn 53
Figure 26. Asia Pacific Pharmacogenomics Market: Mass Spectrometry, 2019-2030, $ mn 54
Figure 27. Asia Pacific Pharmacogenomics Market: Other Technologies, 2019-2030, $ mn 55
Figure 28. Breakdown of Asia Pacific Pharmacogenomics Market by Application, 2019-2030, % of Sales Revenue 56
Figure 29. Asia Pacific Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 57
Figure 30. Asia Pacific Pharmacogenomics Market: Oncology, 2019-2030, $ mn 58
Figure 31. Asia Pacific Pharmacogenomics Market: Infectious Diseases, 2019-2030, $ mn 59
Figure 32. Asia Pacific Pharmacogenomics Market: Neurology/Psychiatry, 2019-2030, $ mn 60
Figure 33. Asia Pacific Pharmacogenomics Market: Cardiovascular, 2019-2030, $ mn 62
Figure 34. Asia Pacific Pharmacogenomics Market: Pain Management, 2019-2030, $ mn 63
Figure 35. Asia Pacific Pharmacogenomics Market: Other Applications, 2019-2030, $ mn 64
Figure 36. Breakdown of Asia Pacific Pharmacogenomics Market by End User, 2019-2030, % of Revenue 65
Figure 37. Asia Pacific Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%) 66
Figure 38. Asia Pacific Pharmacogenomics Market: Hospitals and Clinics, 2019-2030, $ mn 67
Figure 39. Asia Pacific Pharmacogenomics Market: Pharmaceutical Companies, 2019-2030, $ mn 68
Figure 40. Asia Pacific Pharmacogenomics Market: Research Institutes, 2019-2030, $ mn 69
Figure 41. Breakdown of APAC Pharmacogenomics Market by Country, 2019 and 2030, % of Revenue 71
Figure 42. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 72
Figure 43. Pharmacogenomics Market in Japan, 2019-2030, $ mn 74
Figure 44. Pharmacogenomics Market in China, 2019-2030, $ mn 76
Figure 45. Pharmacogenomics Market in Australia, 2019-2030, $ mn 78
Figure 46. Pharmacogenomics Market in India, 2019-2030, $ mn 80
Figure 47. Pharmacogenomics Market in South Korea, 2019-2030, $ mn 82
Figure 48. Pharmacogenomics Market in Rest of APAC, 2019-2030, $ mn 84
Figure 49. Growth Stage of Asia Pacific Pharmacogenomics Industry over the Forecast Period 86